EFTA00617652 In addition, other governmental agencies are also increasingly working with the FDA. The National Institutes of Health (NIH) created the Accelerating Medicines Partnership (AMP) as a new model for spurring development of drugs toward FDA approval. On the reimbursement front, several factors favor companies providing i